K1C19_HUMAN - dbPTM
K1C19_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID K1C19_HUMAN
UniProt AC P08727
Protein Name Keratin, type I cytoskeletal 19
Gene Name KRT19
Organism Homo sapiens (Human).
Sequence Length 400
Subcellular Localization
Protein Description Involved in the organization of myofibers. Together with KRT8, helps to link the contractile apparatus to dystrophin at the costameres of striated muscle..
Protein Sequence MTSYSYRQSSATSSFGGLGGGSVRFGPGVAFRAPSIHGGSGGRGVSVSSARFVSSSSSGAYGGGYGGVLTASDGLLAGNEKLTMQNLNDRLASYLDKVRALEAANGELEVKIRDWYQKQGPGPSRDYSHYYTTIQDLRDKILGATIENSRIVLQIDNARLAADDFRTKFETEQALRMSVEADINGLRRVLDELTLARTDLEMQIEGLKEELAYLKKNHEEEISTLRGQVGGQVSVEVDSAPGTDLAKILSDMRSQYEVMAEQNRKDAEAWFTSRTEELNREVAGHTEQLQMSRSEVTDLRRTLQGLEIELQSQLSMKAALEDTLAETEARFGAQLAHIQALISGIEAQLGDVRADSERQNQEYQRLMDIKSRLEQEIATYRSLLEGQEDHYNNLSASKVL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Phosphorylation------MTSYSYRQS
------CCCCCCCCC
36.0524719451
3Phosphorylation-----MTSYSYRQSS
-----CCCCCCCCCC
15.6928857561
4Phosphorylation----MTSYSYRQSSA
----CCCCCCCCCCC
10.6828857561
5Phosphorylation---MTSYSYRQSSAT
---CCCCCCCCCCCC
17.3824719451
6Phosphorylation--MTSYSYRQSSATS
--CCCCCCCCCCCCC
12.3928857561
7Dimethylation-MTSYSYRQSSATSS
-CCCCCCCCCCCCCC
24.78-
7Methylation-MTSYSYRQSSATSS
-CCCCCCCCCCCCCC
24.7824129315
9PhosphorylationTSYSYRQSSATSSFG
CCCCCCCCCCCCCCC
16.9723911959
10PhosphorylationSYSYRQSSATSSFGG
CCCCCCCCCCCCCCC
27.5123911959
12PhosphorylationSYRQSSATSSFGGLG
CCCCCCCCCCCCCCC
27.1830278072
13PhosphorylationYRQSSATSSFGGLGG
CCCCCCCCCCCCCCC
24.3228355574
14PhosphorylationRQSSATSSFGGLGGG
CCCCCCCCCCCCCCC
24.4528355574
22PhosphorylationFGGLGGGSVRFGPGV
CCCCCCCCCEECCCE
17.2528355574
24Asymmetric dimethylarginineGLGGGSVRFGPGVAF
CCCCCCCEECCCEEE
32.28-
24MethylationGLGGGSVRFGPGVAF
CCCCCCCEECCCEEE
32.2824129315
32MethylationFGPGVAFRAPSIHGG
ECCCEEEECCCCCCC
35.5324129315
35PhosphorylationGVAFRAPSIHGGSGG
CEEEECCCCCCCCCC
26.6627273156
40PhosphorylationAPSIHGGSGGRGVSV
CCCCCCCCCCCCCCC
42.5428355574
43DimethylationIHGGSGGRGVSVSSA
CCCCCCCCCCCCCCE
45.96-
43MethylationIHGGSGGRGVSVSSA
CCCCCCCCCCCCCCE
45.9624129315
46PhosphorylationGSGGRGVSVSSARFV
CCCCCCCCCCCEEEE
21.0728355574
48PhosphorylationGGRGVSVSSARFVSS
CCCCCCCCCEEEEEC
15.6928857561
49PhosphorylationGRGVSVSSARFVSSS
CCCCCCCCEEEEECC
22.7028857561
51MethylationGVSVSSARFVSSSSS
CCCCCCEEEEECCCC
34.1524129315
54PhosphorylationVSSARFVSSSSSGAY
CCCEEEEECCCCCCC
23.0728152594
55PhosphorylationSSARFVSSSSSGAYG
CCEEEEECCCCCCCC
29.0127273156
56PhosphorylationSARFVSSSSSGAYGG
CEEEEECCCCCCCCC
22.4828152594
57PhosphorylationARFVSSSSSGAYGGG
EEEEECCCCCCCCCC
34.4426657352
58PhosphorylationRFVSSSSSGAYGGGY
EEEECCCCCCCCCCC
29.4128152594
61PhosphorylationSSSSSGAYGGGYGGV
ECCCCCCCCCCCCCE
21.5928152594
65PhosphorylationSGAYGGGYGGVLTAS
CCCCCCCCCCEEECC
17.6228152594
70PhosphorylationGGYGGVLTASDGLLA
CCCCCEEECCCCCCC
23.0028152594
72PhosphorylationYGGVLTASDGLLAGN
CCCEEECCCCCCCCC
27.2926657352
81UbiquitinationGLLAGNEKLTMQNLN
CCCCCCCCCCCCCHH
53.9421906983
93PhosphorylationNLNDRLASYLDKVRA
CHHHHHHHHHHHHHH
30.7125106551
94PhosphorylationLNDRLASYLDKVRAL
HHHHHHHHHHHHHHH
17.2026356563
97AcetylationRLASYLDKVRALEAA
HHHHHHHHHHHHHHC
30.9024786549
97UbiquitinationRLASYLDKVRALEAA
HHHHHHHHHHHHHHC
30.9021906983
111UbiquitinationANGELEVKIRDWYQK
CCCCEEEEEEHHHHH
23.7321906983
116PhosphorylationEVKIRDWYQKQGPGP
EEEEEHHHHHCCCCC
15.3222817900
118MethylationKIRDWYQKQGPGPSR
EEEHHHHHCCCCCCC
41.3424583695
118UbiquitinationKIRDWYQKQGPGPSR
EEEHHHHHCCCCCCC
41.3421906983
124PhosphorylationQKQGPGPSRDYSHYY
HHCCCCCCCCCHHHE
43.6428348404
127PhosphorylationGPGPSRDYSHYYTTI
CCCCCCCCHHHEEEH
9.0228857561
128PhosphorylationPGPSRDYSHYYTTIQ
CCCCCCCHHHEEEHH
14.8728857561
130PhosphorylationPSRDYSHYYTTIQDL
CCCCCHHHEEEHHHH
9.1428857561
131PhosphorylationSRDYSHYYTTIQDLR
CCCCHHHEEEHHHHH
7.6228857561
132PhosphorylationRDYSHYYTTIQDLRD
CCCHHHEEEHHHHHH
15.4023312004
133PhosphorylationDYSHYYTTIQDLRDK
CCHHHEEEHHHHHHH
10.6627251275
140UbiquitinationTIQDLRDKILGATIE
EHHHHHHHHHCCEEE
33.1422817900
145PhosphorylationRDKILGATIENSRIV
HHHHHCCEEECCEEE
27.3323312004
149PhosphorylationLGATIENSRIVLQID
HCCEEECCEEEEEEE
15.5922985185
167PhosphorylationLAADDFRTKFETEQA
CCHHHHHHHHHHHHH
39.8321406692
168SumoylationAADDFRTKFETEQAL
CHHHHHHHHHHHHHH
36.63-
168AcetylationAADDFRTKFETEQAL
CHHHHHHHHHHHHHH
36.6327178108
168MethylationAADDFRTKFETEQAL
CHHHHHHHHHHHHHH
36.6372594069
168SumoylationAADDFRTKFETEQAL
CHHHHHHHHHHHHHH
36.63-
168UbiquitinationAADDFRTKFETEQAL
CHHHHHHHHHHHHHH
36.6321906983
171PhosphorylationDFRTKFETEQALRMS
HHHHHHHHHHHHHHH
36.2121406692
178PhosphorylationTEQALRMSVEADING
HHHHHHHHHHHCHHH
15.4624719451
194PhosphorylationRRVLDELTLARTDLE
HHHHHHHHHHCCCHH
19.1424719451
198PhosphorylationDELTLARTDLEMQIE
HHHHHHCCCHHHHHH
39.0520068231
208SumoylationEMQIEGLKEELAYLK
HHHHHHHHHHHHHHH
61.06-
208SumoylationEMQIEGLKEELAYLK
HHHHHHHHHHHHHHH
61.06-
208UbiquitinationEMQIEGLKEELAYLK
HHHHHHHHHHHHHHH
61.0621906983
213PhosphorylationGLKEELAYLKKNHEE
HHHHHHHHHHHCCHH
31.5121118733
215SumoylationKEELAYLKKNHEEEI
HHHHHHHHHCCHHHH
38.56-
215SumoylationKEELAYLKKNHEEEI
HHHHHHHHHCCHHHH
38.56-
215UbiquitinationKEELAYLKKNHEEEI
HHHHHHHHHCCHHHH
38.5621906983
216UbiquitinationEELAYLKKNHEEEIS
HHHHHHHHCCHHHHH
62.0221906983
223PhosphorylationKNHEEEISTLRGQVG
HCCHHHHHHHCCCCC
25.3524719451
224PhosphorylationNHEEEISTLRGQVGG
CCHHHHHHHCCCCCC
26.5723312004
234PhosphorylationGQVGGQVSVEVDSAP
CCCCCEEEEEEECCC
12.5026657352
239PhosphorylationQVSVEVDSAPGTDLA
EEEEEEECCCCCCHH
41.3528348404
243PhosphorylationEVDSAPGTDLAKILS
EEECCCCCCHHHHHH
27.1222468782
247UbiquitinationAPGTDLAKILSDMRS
CCCCCHHHHHHHHHH
52.0221906983
250PhosphorylationTDLAKILSDMRSQYE
CCHHHHHHHHHHHHH
32.6024719451
254PhosphorylationKILSDMRSQYEVMAE
HHHHHHHHHHHHHHH
30.4026356563
256PhosphorylationLSDMRSQYEVMAEQN
HHHHHHHHHHHHHHH
16.2526356563
265UbiquitinationVMAEQNRKDAEAWFT
HHHHHHHHHHHHHHH
69.6921906983
272PhosphorylationKDAEAWFTSRTEELN
HHHHHHHHHHHHHHH
13.4428348404
273PhosphorylationDAEAWFTSRTEELNR
HHHHHHHHHHHHHHH
27.9427251275
275PhosphorylationEAWFTSRTEELNREV
HHHHHHHHHHHHHHH
33.3127251275
286PhosphorylationNREVAGHTEQLQMSR
HHHHCCCHHHHHCCH
25.2223312004
292PhosphorylationHTEQLQMSRSEVTDL
CHHHHHCCHHHHHHH
21.5023312004
294PhosphorylationEQLQMSRSEVTDLRR
HHHHCCHHHHHHHHH
29.1624719451
302PhosphorylationEVTDLRRTLQGLEIE
HHHHHHHHHHHHHHH
19.5920068231
312PhosphorylationGLEIELQSQLSMKAA
HHHHHHHHHHHHHHH
45.7920068231
315PhosphorylationIELQSQLSMKAALED
HHHHHHHHHHHHHHH
15.5930278072
317UbiquitinationLQSQLSMKAALEDTL
HHHHHHHHHHHHHHH
27.4221906983
323PhosphorylationMKAALEDTLAETEAR
HHHHHHHHHHHHHHH
20.6328355574
327PhosphorylationLEDTLAETEARFGAQ
HHHHHHHHHHHHHHH
29.3620860994
343PhosphorylationAHIQALISGIEAQLG
HHHHHHHHCHHHHHC
34.2724719451
370UbiquitinationYQRLMDIKSRLEQEI
HHHHHHHHHHHHHHH
25.8422817900
371PhosphorylationQRLMDIKSRLEQEIA
HHHHHHHHHHHHHHH
42.2930087585
379PhosphorylationRLEQEIATYRSLLEG
HHHHHHHHHHHHHCC
25.73-
380PhosphorylationLEQEIATYRSLLEGQ
HHHHHHHHHHHHCCC
6.81-
382PhosphorylationQEIATYRSLLEGQED
HHHHHHHHHHCCCHH
27.2226356563
391PhosphorylationLEGQEDHYNNLSASK
HCCCHHHCCCCCHHH
20.3330278072
395PhosphorylationEDHYNNLSASKVL--
HHHCCCCCHHHCC--
32.4024670416
397PhosphorylationHYNNLSASKVL----
HCCCCCHHHCC----
21.6630278072
398UbiquitinationYNNLSASKVL-----
CCCCCHHHCC-----
47.4721906983

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
35SPhosphorylationKinaseAKT1P31749
PSP
391YPhosphorylationKinaseSRCP12931
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of K1C19_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of K1C19_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
HGS_HUMANHGSphysical
16189514
DGC6L_HUMANDGCR6Lphysical
16189514
SFI1_HUMANSFI1physical
16189514
ABI2_HUMANABI2physical
16189514
PCM1_HUMANPCM1physical
16189514
DEPP_HUMANC10orf10physical
16189514
EXOC8_HUMANEXOC8physical
16189514
ZN638_HUMANZNF638physical
16189514
USBP1_HUMANUSHBP1physical
16189514
F107A_HUMANFAM107Aphysical
16189514
KDM1A_HUMANKDM1Aphysical
23455924
K1C19_HUMANKRT19physical
25416956
UBC9_HUMANUBE2Iphysical
25416956
IF4E2_HUMANEIF4E2physical
25416956
RPAC1_HUMANPOLR1Cphysical
25416956
IKZF3_HUMANIKZF3physical
25416956
TFPT_HUMANTFPTphysical
25416956
TBCD7_HUMANTBC1D7physical
25416956
AMOL2_HUMANAMOTL2physical
25416956
CA109_HUMANC1orf109physical
25416956
4ET_HUMANEIF4ENIF1physical
25416956
CC146_HUMANCCDC146physical
25416956
CARD9_HUMANCARD9physical
25416956
F124B_HUMANFAM124Bphysical
25416956
HAUS1_HUMANHAUS1physical
25416956
PPR18_HUMANPPP1R18physical
25416956
CE57L_HUMANCEP57L1physical
25416956

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of K1C19_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-97, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-40, AND MASSSPECTROMETRY.
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells.";
Kim J.-E., Tannenbaum S.R., White F.M.;
J. Proteome Res. 4:1339-1346(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35 AND SER-46, AND MASSSPECTROMETRY.
"Characterization of the major physiologic phosphorylation site ofhuman keratin 19 and its role in filament organization.";
Zhou X., Liao J., Hu L., Feng L., Omary M.B.;
J. Biol. Chem. 274:12861-12866(1999).
Cited for: PHOSPHORYLATION AT SER-35, AND MUTAGENESIS OF SER-10 AND SER-35.
"Characterization of in vivo keratin 19 phosphorylation on tyrosine-391.";
Zhou Q., Snider N.T., Liao J., Li D.H., Hong A., Ku N.O.,Cartwright C.A., Omary M.B.;
PLoS ONE 5:E13538-E13538(2010).
Cited for: PHOSPHORYLATION AT TYR-391.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-130, AND MASSSPECTROMETRY.

TOP